Early Invasive Strategy for Stable CAD Holds No Long-Term Survival Advantage

(MedPage Today) -- CHICAGO--An early interventional strategy for stable ischemic heart disease didn't hold a long-term mortality advantage over initial medical managment in extended follow-up from the landmark ISCHEMIA trial.
All-cause mortality...